CLINICAL_TRIALS
trial_result
· 2022-11-10
Clinical Trial Update: A Study to Evaluate the Efficacy of SAGE-217 in the Treatment of Adult Participants With Major Depressive Disorder [Phase 3]
Summary
Phase 3 trial evaluating SAGE-217 for treatment of adult major depressive disorder has completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biogen | Conditions: Major Depressive Disorder | Phase 3 | Status: COMPLETED | Results posted: 2022-11-10